|View printer-friendly version|
|Quidel Corporation -Nasdaq: QDEL- Posts Information On the Web to Educate the Public About Influenza Testing and Pathogens That Can Cause Flu-like Symptoms|
SAN DIEGO, Calif.--(BW HealthWire)--Nov. 19, 2001--Quidel Corporation (Nasdaq: QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, today unveiled a section on their website (www.quidel.com) devoted to providing timely and topical information to healthcare professionals, consumers and members of the media on the benefits of influenza testing this winter.
The site, called "Don't Guess, Test," contains information on influenza, influenza testing and pathogens ranging from the more common, such as respiratory syncitial virus (RSV), to the very rare, such as anthrax, that can cause flu-like symptoms. It is in an easy to read "Frequently Asked Questions" format. The site also contains useful informational links to federal public health agencies like the CDC and FDA as well as a link to the AMA's "disaster preparedness" site.
"Ironically, we have an opportunity to save more lives this flu season than ever before due to the public's concerns about flu-like symptoms. Influenza testing is a widely available and proven means to help doctors diagnose influenza and help allay public fears during this flu season. Quidel's commitment to serving as a trusted source of responsible medical information is as strong as ever," said S. Wayne Kay, President and CEO of Quidel.
About Quidel's QuickVue Influenza Test
Quidel's QuickVue Influenza test is a simple, three-step, one-reagent test using a nasal swab or nasal wash that provides results in ten minutes, or less. The test is CLIA-waived, allowing the patient to be tested and treated in one office visit.
About Quidel Corporation
Quidel Corporation discovers, develops, manufactures and markets rapid point-of-care, diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's health, in areas such as reproduction and diseases of the elderly. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia, infectious mononucleosis, and infectious vaginitis. Quidel's products are sold to healthcare professionals for use in physician offices, clinical laboratories and pharmacies, and to consumers through organizations that provide private label, store brand products. These tests provide diagnostic information to enable rapid treatment and improve health outcomes, lower costs, and increase patient satisfaction. For more information, please visit Quidel's website at http://www.quidel.com.
Note to All Editors: B-roll footage of S. Wayne Kay and related subject matter regarding influenza testing is available via satellite on Monday, November 19 and Tuesday November 20 at 10:00AM eastern standard time by accessing the following coordinates: Monday, November 19, 2001 (10:00 - 10:30 AM ET) Coordinates: C_BAND: TELSTAR 5 (C) /TRANSPONDER 16 /AUDIO 6.2 & 6.8 Tuesday, November 20, 2001 (10:00 - 10:30 AM ET) Coordinates: C_BAND: TELSTAR 5 (C) /TRANSPONDER 16 /AUDIO 6.2 & 6.8